SCHEMBL10167907

SCHEMBL10167907

Bc1cccc2c1c(=O)c1ccccc1n2C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.66
MAPT P10636 1/20 0.66
GPR3 P46089 1/20 0.50
KDM1A O60341 1/20 0.49
ATM Q13315 1/20 0.49
CYP2C19 P33261 2/20 0.47
HSD17B10 Q99714 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
NTRK1 P04629 2/20 0.44
PABPC1 P11940 1/20 0.44
HKDC1 Q2TB90 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HCRTR1 O43613 1/20 0.43
NQO2 P16083 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14802158 0.81 MAPT (0.68) HTTMAPTGPR3KDM1AATM
SCHEMBL10977307 0.79 HTT (0.66) HTTMAPTGPR3KDM1AATM
SCHEMBL382974 0.79 HTT (0.66) HTTMAPTGPR3KDM1AATM
SCHEMBL9352178 0.79 HTT (1.00) HTTMAPTGPR3KDM1AATM
SCHEMBL21312375 0.79 GPR3 (0.71) HTTMAPTGPR3KDM1AATM
SCHEMBL29466066 0.79 GPR3 (0.71) HTTMAPTGPR3ATMCYP2C19
SCHEMBL53107 0.79 GPR3 (0.71) HTTMAPTGPR3ATMCYP2C19
SCHEMBL13633669 0.76 HTT (0.61) HTTMAPTGPR3KDM1AATM
SCHEMBL21564036 0.76 HTT (0.61) HTTMAPTGPR3KDM1AATM
SCHEMBL10168172 0.74 MAPT (0.59) HTTMAPTGPR3KDM1AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1330456-B9 N8,N13 -DISUBSTITUTED QUINO[4,3,2-KL]ACRIDINIUM SALTS AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2012-01-25 EP disclosed
EP-1330456-B1 N8,N13 -DISUBSTITUTED QUINO[4,3,2-KL]ACRIDINIUM SALTS AS THERAPEUTIC AGENTS CANCER REC TECH LTD (GB) 2011-06-15 EP disclosed